Host factors associated with outcome from primary human immunodeficiency virus-1 infection

被引:6
作者
Telenti, Amalio [1 ,2 ]
Carrington, Mary [3 ]
机构
[1] Univ Lausanne, Inst Microbiol, CH-1011 Lausanne, Switzerland
[2] Univ Hosp Ctr, Inst Microbiol, CH-1011 Lausanne, Switzerland
[3] NCI Frederick, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick Inc, Frederick, MD 21702 USA
基金
美国国家卫生研究院; 瑞士国家科学基金会;
关键词
genome; HLA antigens; KIR receptors; viral load;
D O I
10.1097/COH.0b013e3282f18ac0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose of review The early events in human immunodeficiency virus-1 infection are increasingly recognized as critical for the overall evolution of the disease. Viral and host factors interact to establish a point of equilibrium defined by the viral set point. This review highlights new opportunities in the understanding of the genetic and genomic determinants of those early events. Recent findings The field of human immunodeficiency virus host genetics is shifting from the measure of long-term consequences of infection to the analysis of quantitative biological endpoints of viral control, with particular attention on the earliest events as study phenotypes. The field has also been enriched by a better understanding of the determinant and complex role of human leukocyte antigen and killer cell immunoglobulin-like-receptor variation, and by the completion of the first genome-wide study of determinants of human immunodeficiency virus-1 replication. The genome analysis highlights the central influence of acquired immunity in viral control, and provides an extensive catalogue of novel gene candidates. Summary Host genetics and genomic analyses of precise quantitative study phenotypes offer an unprecedented opportunity to dissect critical steps in human immunodeficiency virus-1 pathogenesis.
引用
收藏
页码:28 / 35
页数:8
相关论文
共 50 条
  • [1] Human immunodeficiency virus-1 infection in neonates: Correlation of plasma and cellular viremia and clinical outcome
    Rouzioux, C
    Burgard, M
    Chaix, ML
    Delamare, C
    Ivanoff, S
    Bouiller, B
    Cateloy, S
    Allemon, MC
    Broyart, C
    Ciraru, N
    Floch, C
    Lelorier, P
    Lachassine, E
    Mazy, F
    Narcy, P
    Saillant, J
    Salomon, JL
    Seaume, H
    Talon, P
    Mayaux, MJ
    Blanche, S
    ACTA PAEDIATRICA, 1997, 86 : 17 - 21
  • [2] Complete Human Immunodeficiency Virus-1 Specific T Lymphocyte Response to Chinese Human Immunodeficiency Virus-1 B/C Chronic Infectors
    Wang, Zhe
    Liu, Hong-Wei
    Hong, Kun-Xue
    Yu, Zu-Jiang
    Chen, Jian-Ping
    Ruan, Yu-Hua
    Kan, Quan-Cheng
    Shao, Yi-Ming
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2009, 22 (06) : 522 - 528
  • [3] Early diagnosis of human immunodeficiency virus-1 infection in infants with the NucliSens EasyQ assay on dried blood spots
    Lilian, R. R.
    Bhowan, K.
    Sherman, G. G.
    JOURNAL OF CLINICAL VIROLOGY, 2010, 48 (01) : 40 - 43
  • [4] Quantifying the Impact of Human Immunodeficiency Virus-1 Escape From Cytotoxic T-Lymphocytes
    Kadolsky, Ulrich D.
    Asquith, Becca
    PLOS COMPUTATIONAL BIOLOGY, 2010, 6 (11)
  • [5] Dynamic correlation between CTL response and viral load in primary human immunodeficiency virus-1 infected Koreans
    Gab Jung Kim
    Hak Sung Lee
    Kee-Jong Hong
    Sung Soon Kim
    Virology Journal, 7
  • [6] G-Quadruplexes in the Human Immunodeficiency Virus-1 and Herpes Simplex Virus-1: New Targets for Antiviral Activity by Small Molecules
    Perrone, Rosalba
    Artusi, Sara
    Butovskaya, Elena
    Nadai, Matteo
    Pannecouque, Christophe
    Richter, Sara N.
    5TH INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING IN VIETNAM, 2015, 46 : 207 - 210
  • [7] Novelties in Evaluation and Monitoring of Human Immunodeficiency Virus-1 Infection: Is Standard Virological Suppression Enough for Measuring Antiretroviral Treatment Success?
    Svicher, Valentina
    Marchetti, Giulia
    Ammassari, Adrianna
    Ceccherini-Silberstein, Francesca
    Sarmati, Loredana
    AIDS REVIEWS, 2017, 19 (03) : 119 - 133
  • [8] Risk Factors for Venous Thromboembolism in Patients with Human Immunodeficiency Virus Infection
    Kiser, Katie L.
    Badowski, Melissa E.
    PHARMACOTHERAPY, 2010, 30 (12): : 1292 - 1302
  • [9] Molecular monitoring of human immunodeficiency virus type 1 infection
    Clementi, M
    Bagnarelli, P
    Menzo, S
    Cardelli, M
    Mazzola, F
    Sampaolesi, R
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 1997, 11 (1-2) : 64 - 68
  • [10] Diagnosis of Human Immunodeficiency Virus Infection
    Parekh, Bharat S.
    Ou, Chin-Yih
    Fonjungo, Peter N.
    Kalou, Mireille B.
    Rottinghaus, Erin
    Puren, Adrian
    Alexander, Heather
    Cox, Mackenzie Hurlston
    Nkengasong, John N.
    CLINICAL MICROBIOLOGY REVIEWS, 2019, 32 (01)